Drug Profile
Lohocla 201
Alternative Names: Kindolor®; Lohocla-201Latest Information Update: 03 Nov 2023
Price :
$50
*
At a glance
- Originator Lohocla Research
- Class Analgesics; Small molecules
- Mechanism of Action Nav1.7 voltage-gated sodium channel modulators; Nav1.8 voltage-gated sodium channel modulators; NMDA receptor modulators; Opioid delta receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Pain
- No development reported Anxiety disorders
Most Recent Events
- 31 Oct 2023 US FDA approves IND application for Lohocla 201 in chronic Pain
- 31 Oct 2023 Lohocla Research plans a first-in-human phase I trial for chronic Pain in USA (PO), in the first quarter of 2024
- 22 Sep 2023 Lohocla Research Corporation plans a phase I trial for diabetic neuropathy in 2023 (Lohocla Research Corporation, website 2023)